 Home > Active Ingredient News > Study of Nervous System > Express 7:2! The innovative treatment of "frostbite" is supported by the FDA Expert Committee

Express 7:2! The innovative treatment of "frostbite" is supported by the FDA Expert Committee

 Last Update: 2022-09-14
 Source: Internet
 Author: User

▎ WuXi AppTec content team editor

Today, members of the Advisory Committee on Drugs of the Peripheral and Central Nervous Systems (PCNS), convened by the U.

Screenshot source: References[1]

ALS (aka Frostbite) has received a lot of attention

Amylyx's AMX0035 is designed to skip the complexity of the nervous system and directly delay the death

▲The mechanism of AMX0035 (Image source: Amylyx official website)

The efficacy of this therapy was supported by a Phase 2 clinical trial, CENTAUR, in which patients treated significantly reduced the average score decline compared to the placebo group after 24 weeks using alsfrs-R scores that comprehensively measure daily functioning in als patients

▲AMX0035 significantly improves ALSFRS-R score (Image source: Amylyx official website)

At this advisory board meeting, Amylyx described an up-to-date analysis of the available data and the results of a biomarker for the AMX0035 clinical trial to treat Alzheimer's disease (see: With just over 150 years of history and only 2 FDA-approved therapies, can a deadly disease accelerate the emergence of innovative therapies?).

The ALS field has received more attention and R&D investment

WuXi AppTec provides integrated, end-to-end new drug development and production services to the global biopharmaceutical industry, covering chemical drug development and production, biological research, preclinical and clinical trial development, cell and gene therapy research and development, testing and production

▲If you have any business needs, please long press to scan the QR code above, or

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Sodium bromide airuike

CAS No.: 7647-15-6

Industrial Grade

$10/KG EXW

Brivaracetam357336-20-0

CAS No.: 357336-20-0

API Grade

$100/KG EXW

Quetiapine fumarate CAS 111974-72-2

CAS No.: 111974-72-2

Pharmaceutical Grade

$100/KG EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.